Bruce R Blazar

Bruce R Blazar is a Regents Professor and Associate Vice President in the Health Sciences Administration Office of Academic Clinical Affairs at the University of Minnesota. He is affiliated with the Medical School and the Department of Pediatric Blood & Marrow Transplant & Cellular Therapy, and is a key member of the Center for Immunology. His work bridges clinical practice, translational research, and academic leadership.

His research focuses on graft-versus-host disease (GvHD), regulatory T cells, and cellular therapies in the context of hematopoietic stem cell transplantation. He employs preclinical models, metabolomics, and clinical trials to understand immune dysregulation and develop novel immunomodulatory strategies. His work contributes to advancing treatments for transplant complications and improving patient outcomes.

The trends in his recent publications (2020–2025) reveal a strong emphasis on cell-based therapies, particularly regulatory T cell engineering, and the molecular mechanisms of GvHD. He investigates how metabolic and genetic factors influence immune responses and graft outcomes, with applications in both acute and chronic GvHD. His work spans basic science, translational models, and clinical trials, reflecting a comprehensive approach to immunotherapy.

Bruce R Blazar has been principal investigator on numerous high-impact research grants, including projects funded by the NIH, Stanford University, and Massachusetts General Hospital. These projects focus on

• Orthogonal IL2 receptor transduced Tregs for clinical use
• Metabolomics of chronic GVHD
• Lung allograft tolerance in non-human primates
• Prevention of murine GVHD
• University of Minnesota Clinical and Translational Science Institute (UMN CTSI)

His leadership in these initiatives underscores his role in advancing translational immunology and collaborative science.

He has mentored numerous researchers and collaborators, as evidenced by his extensive publication record and co-authorship with junior scientists. His dataset on Alpha-defensin gene polymorphism and gut microbiota highlights his interest in host-microbe interactions in transplant settings. He has also presented work on predictors of flares in chronic GVHD, contributing to clinical understanding of disease dynamics.